Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Withdrawn × NET × Clear all

Phase

Phase 2 6 Phase 1/2 2 Phase 1 2 Phase NA 1 Phase EARLY_PHASE1 1 Phase 4 1 Phase 3 1

Status

Completed 13 Recruiting 11 Active not recruiting 6 Terminated 3 Withdrawn 1 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 31 Genitourinary 26 Breast 22 Thoracic 18 Lymphoid 16 Other hematologic neoplasm 11 Gynecologic 11 Head & Neck 10 CNS 8 Tumor-Agnostic 4 Sarcoma 4 Dermatologic 4 Myeloid 3 Endocrine 3 Plasma cell 2 Other solid neoplasm 1 Other neoplasm 1 Other 1 NET 1 Classical hematology 1

Conditions

Neuroendocrine Tumors 1

Interventions

lutetium Lu 177 dotatate 1 Introns 1 177Lu-octreotate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01860742 2016-04-05

CASTOR

Jules Bordet Institute

Phase 3 Withdrawn

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡